“When it comes to AI, iCAD was the first in the game. Although AI itself is still in its infancy, iCAD is ahead of other companies that are just now entering the market of breast AI. Additionally, the data supporting ProFound AI speaks for itself. After looking at reader studies for other AI solutions, we were not as confident that what they were offering was as robust as iCAD’s technology.”

Arnold B. Honick, MD, Diagnostic Radiology Specialist at RCI

“After using ProFound AI for about a month, we were sold. This leading-edge AI solution accurately identifies suspicious lesions and provides Certainty of Finding scores, which help to improve our team’s confidence in making clinical decisions. With results displayed conveniently on our reading station, ProFound AI acts as a real safety net, as it empowers our team to catch even the smallest and most difficult to detect lesions.”

Rafaële Baulieux Vautrin, MD, Radiologist Imapole, France

“For radiologists who may not have as much experience with DBT, ProFound AI is a great tool, as it can help ensure they’re being thorough and adequately going through every single image slice. For radiologists who have more experience with DBT, ProFound AI provides additional confirmation and clinical confidence to ensure we’re doing a good job for our patients.”

Joshua A. Nepute, MD, Radiologist, IU Health Frankfort, IU Health Arnett, IU Health White Memorial

“As a diagnostic radiologist, I’m not reading nearly as many mammograms as someone reading screening mammograms, but I have still grown to rely on the technology. I see a fair number of screening callbacks, and when I review the diagnostic images, I rely heavily on the areas of concern detected by ProFound AI on the original screening mammogram. I have come to appreciate that when ProFound AI indicates the risk of malignancy is low, you can almost always trust it. And for my colleagues who do large volume screening mammography, ProFound AI serves as a reliable ‘second reader’ that helps them avoid making errors in interpretation.”

William G. Way Jr., MD, Diagnostic Radiologist at Wake Radiology

“With ProFound AI, my MQSA numbers are the best they have ever been in my career, in terms of cancer detection and callback rate. I can easily read at least 100 screening mammography cases per day. ProFound AI reduces my stress and worries while reading 3D mammography, and my job satisfaction has improved considerably. This technology offers a triple win: it helps radiologists detect more cancers, with fewer unnecessary callbacks, and in less than half the time. This technology is poised to transform breast cancer detection and improve patient lives in the years ahead. I would not send a loved one to a mammography center that didn't have ProFound AI, and there is no way that I would ever read without it.”

Mark Traill, MD, University of Michigan Health-West

“We have done a thorough evaluation of all of the other available AI technologies for breast imaging, but ultimately we found ProFound AI to be the best solution. With its multi-vendor flexibility, ProFound AI seamlessly integrated into our system and clinical workflow.”

Matt Dewey, Chief Information Officer, Wake Radiology

“ProFound AI as a clinical tool for radiologists has the potential to reduce interval cancer rates by detecting cancers that are already present in the screening round but are perhaps undetected or missed by the readers. Using this technology at the screening level could limit the number of false negatives and help to detect a large proportion of the minimal sign cancers, which could ensure earlier treatment and better chances of recovery for these women.”

Axel Gräwingholt, MD, Radiologie am Theater, Paderborn, Germany